Hemorrhagic Stroke

Magnesium Has No Effect on Cognitive Outcomes Following Aneurysmal Subarachnoid Hemorrhage

Magnesium Has No Effect on Cognitive Outcomes Following Aneurysmal Subarachnoid Hemorrhage

By

In the linear analysis, study investigators found no significant effect of magnesium on cognition.

Early Lactic Acidemia Common in Aneurysmal Subarachnoid Hemorrhage

Early Lactic Acidemia Common in Aneurysmal Subarachnoid Hemorrhage

By

Serum lactate at admission did not correlate with vasospasm or delayed cerebral ischemia development.

Early Neurological Deterioration in Intracranial Hemorrhage Linked to Worse Outcomes

Early Neurological Deterioration in Intracranial Hemorrhage Linked to Worse Outcomes

By

One in 8 patients with ACI experience ultra-early neurological deterioration during ambulance transport and initial evaluation at the emergency department.

Combo Therapy With Probucol May Prevent Cardiovascular Events in Stroke Patients at Risk for ICH

Combo Therapy With Probucol May Prevent Cardiovascular Events in Stroke Patients at Risk for ICH

By

A team of investigators sought to assess the efficacy and safety of cilostazol vs aspirin, both with and without probucol, a cholesterol-lowering agent, in Asian patients with ischemic stroke.

Cerebral Microbleeds as Biomarker for Hemorrhage Risk in Anticoagulated AFib

Cerebral Microbleeds as Biomarker for Hemorrhage Risk in Anticoagulated AFib

By

Investigators assessed the presence of cerebral microbleeds as a biomarker for identifying patients at increased risk for intracranial hemorrhage as a result of anticoagulation for atrial fibrillation.

Disparities for Risk of Recurrent Hemorrhagic Stroke Unexplained

Disparities for Risk of Recurrent Hemorrhagic Stroke Unexplained

Black and Hispanic patients are at higher risk for stroke recurrence than white patients.

Cerebral Microbleeds Do Not Predict 3-Month Death or Disability in Intracerebral Hemorrhage

Cerebral Microbleeds Do Not Predict 3-Month Death or Disability in Intracerebral Hemorrhage

By

Investigators performed a pre-planned secondary analysis of the open-label, randomized Antihypertensive Treatment of Acute Cerebral Hemorrhage 2 study, specifically on the magnetic resonance images obtained during the intensive blood pressure lowering portion of the trial.

Intracerebral Hemorrhage-Related Hospital Mortality Reduced With Prior NOAC Use

Intracerebral Hemorrhage-Related Hospital Mortality Reduced With Prior NOAC Use

By

Outcomes in intracerebral hemorrhage are less severe in patients with prior NOAC use.

Risk Factors Have Varying Effects on Stroke Pathology

Risk Factors Have Varying Effects on Stroke Pathology

By

The results confirm that ischemic, hemorrhagic, and subarachnoid stroke have very different etiologies.

Spontaneous Subarachnoid Hemorrhage Incidence Up in Pregnant Women

Spontaneous Subarachnoid Hemorrhage Incidence Up in Pregnant Women

By

Researchers have observed an upward trend in the incidence of pregnancy-related spontaneous subarachnoid hemorrhage.

ENCHANTED Update: No Role for Low-Dose Alteplase After All?

ENCHANTED Update: No Role for Low-Dose Alteplase After All?

By

Results from a secondary analysis of the ENCHANTED trial add to a pile of weak data that likely will not affect clinical practice.

Noncontrast CT Markers Predict Hematoma Growth Risk in Hemorrhagic Stroke

Noncontrast CT Markers Predict Hematoma Growth Risk in Hemorrhagic Stroke

By

Surprisingly, no evidence was found to suggest that patients with these markers benefit from intensive blood pressure reduction.

Intensive BP Lowering Does Not Benefit ICH With Spot Sign

Intensive BP Lowering Does Not Benefit ICH With Spot Sign

By

Although spot sign predicted ICH expansion, it proved to be a less robust diagnostic marker than demonstrated by previous single-center cohort studies.

Cirrhosis Associated With Increased Stroke Risk

Cirrhosis Associated With Increased Stroke Risk

By

Patients with cirrhosis had a 2.17% per year incidence of stroke compared with 1.11% per year incidence of stroke in patients without cirrhosis.

Intracranial Hemorrhage Associated with Arteriovenous Malformations Linked to Better Outcomes

Intracranial Hemorrhage Associated with Arteriovenous Malformations Linked to Better Outcomes

By

Compared with other sources of ICH, those associated with arteriovenous malformations had lower odds of death.

After Stroke, Intensive Antiplatelet Therapy Has Benefits, Drawbacks

After Stroke, Intensive Antiplatelet Therapy Has Benefits, Drawbacks

By

Intensive antiplatelet therapy appears to reduce risk of recurrence immediately after stroke, but may pose risks further out.

Intracerebral Hemorrhage Outcomes Improved With Anticoagulants

Intracerebral Hemorrhage Outcomes Improved With Anticoagulants

By

Resumption of oral anticoagulants after intracerebral hemorrhage was found to improve outcomes at 1 year.

Oral Anticoagulation After ICH: Risks and Outcomes

Oral Anticoagulation After ICH: Risks and Outcomes

By

Restarting anticoagulation after both nonlobar and lobar ICH was associated with decreased mortality.

Medical Complications After ICH: Changes in the Last Decade

Medical Complications After ICH: Changes in the Last Decade

By

As more patients survive ICH, emphasis is slowly shifting from survival to improving ICH-related morbidity and optimization of functional recovery.

Cilostazol Helps Prevent Secondary Stroke But Not Without Risk

Cilostazol Helps Prevent Secondary Stroke But Not Without Risk

By

Optimal antiplatelet treatment has yet to be determined for stroke survivors with prior intracerebral hemorrhage.

In Stroke, No Clear Benefit for Head Positioning

In Stroke, No Clear Benefit for Head Positioning

By

Neither lying flat nor sitting up appears to alter outcomes in patients presenting with acute stroke.

Dementia, Depression Common After Intracerebral Hemorrhage

Dementia, Depression Common After Intracerebral Hemorrhage

By

Among ICH survivors, 63% developed both depression and dementia during a 5-year follow-up study.

Antiplatelet Pretreatment Linked to Intracranial Hemorrhage Mortality

Antiplatelet Pretreatment Linked to Intracranial Hemorrhage Mortality

By

Patients receiving treatment with vitamin K antagonists (VKA) or antiplatelet agents face a significantly increased risk of mortality within 24 hours of intracranial hemorrhage.

Neonatal Hemorrhagic Stroke: Prevalence and Outcomes

Neonatal Hemorrhagic Stroke: Prevalence and Outcomes

By

Despite being more common than thought, many cases of neonatal hemorrhagic stroke remain idiopathic.

SSRI Use Tied to Risk of Intracranial Hemorrhage

SSRI Use Tied to Risk of Intracranial Hemorrhage

By

Concomitant use of oral anticoagulants contributed to a significantly higher increased risk for ICH.

Weight Linked to Ischemic, But Not Hemorrhagic Stroke in Women

Weight Linked to Ischemic, But Not Hemorrhagic Stroke in Women

Being overweight may slightly lower chances for hemorrhagic stroke, the study found.

Hypocalcemia May Worsen Bleeding in Intracerebral Hemorrhage

Hypocalcemia May Worsen Bleeding in Intracerebral Hemorrhage

By

Lower serum calcium levels correlate with risk of hematoma expansion in intracerebral hemorrhage.

Hemoglobin Level Adversely Impacts Stroke Mortality

Hemoglobin Level Adversely Impacts Stroke Mortality

By

Associations with increased mortality were found for both low and high hemoglobin levels, suggesting a U-shaped relationship.

90% of Stroke Worldwide Attributable to 10 Modifiable Risk Factors

90% of Stroke Worldwide Attributable to 10 Modifiable Risk Factors

By

Still, regional variations exist, indicating that more personalized prevention programs may be needed.

Recommended Reversal Time of Vitamin K Antagonists Identified for ICH

Recommended Reversal Time of Vitamin K Antagonists Identified for ICH

By

As ICH volume is known to increase within the first 3 hours following intracerebral hemorrhage, timely reversal is vital for patients on anticoagulation.

Sign Up for Free e-newsletters



CME Focus